{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:06:26Z","timestamp":1787843186157,"version":"build-2784847793"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s40801-019-00174-7","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T13:02:47Z","timestamp":1576587767000},"page":"41-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy"],"prefix":"10.1007","volume":"7","author":[{"given":"Cristina","family":"Scavone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Di Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Futura","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Trama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Aiezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Rafaniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"key":"174_CR1","unstructured":"Agenzia Italiana del Farmaco. Zyloric. Riassunto delle Caratteristiche del Prodotto. https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_007046_021259_RCP.pdf&retry=0&sys=m0b1l3. Accessed 14 Mar 2019."},{"key":"174_CR2","doi-asserted-by":"publisher","first-page":"3872065","DOI":"10.1155\/2019\/3872065","volume":"2019","author":"XJ Chen","year":"2019","unstructured":"Chen XJ, Eirin A, Kane GC, Misra S, Textor SC, Lerman A, Lerman LO. Impact of Serum Uric Acid Levels on Outcomes following Renal Artery Revascularization in Patients with Renovascular Disease. Int J Hypertens. 2019;2019:3872065. https:\/\/doi.org\/10.1155\/2019\/3872065.","journal-title":"Int J Hypertens."},{"key":"174_CR3","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/jch.12855","volume":"18","author":"T Qin","year":"2016","unstructured":"Qin T, Zhou X, Wang J, Wu X, Li Y, Wang L, Huang H, Li J. Hyperuricemia and the prognosis of hypertensive patients: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2016;18:1268\u201378. https:\/\/doi.org\/10.1111\/jch.12855.","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"174_CR4","volume-title":"Diuretics and other agents employed in the mobilization of edema fluid, Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"IM Weiner","year":"1993","unstructured":"Weiner IM. Diuretics and other agents employed in the mobilization of edema fluid, Goodman and Gilman\u2019s the pharmacological basis of therapeutics. New York: McGraw-Hill; 1993."},{"key":"174_CR5","doi-asserted-by":"publisher","first-page":"d8190","DOI":"10.1136\/bmj.d8190","volume":"344","author":"HK Choi","year":"2012","unstructured":"Choi HK, Soriano LC, Zhang Y, Rodr\u00edguez LA. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ. 2012;344:d8190. https:\/\/doi.org\/10.1136\/bmj.d8190.","journal-title":"BMJ"},{"key":"174_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1023\/B:CARD.0000015855.02485.e3","volume":"17","author":"AJ Reyes","year":"2003","unstructured":"Reyes AJ. Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther. 2003;17:397\u2013414.","journal-title":"Cardiovasc Drugs Ther"},{"key":"174_CR7","unstructured":"Qurie A, Musa R. Allopurinol. [Updated 2018 Dec 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499942\/ Accessed 14 Mar 2019."},{"key":"174_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1445-5994.2005.00790.x","volume":"35","author":"MS Lin","year":"2005","unstructured":"Lin MS, Dai YS, Pwu RF, Chen YH, Chang NC. Risk estimates for drugs suspected of being associated with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a case-control study. Intern Med J. 2005;35:188\u201390.","journal-title":"Intern Med J"},{"key":"174_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2165\/11533190-000000000-00000","volume":"11","author":"TF Tsai","year":"2010","unstructured":"Tsai TF, Yeh TY. Allopurinol in dermatology. Am J Clin Dermatol. 2010;11:225\u201332.","journal-title":"Am J Clin Dermatol"},{"key":"174_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s40264-013-0084-0","volume":"36","author":"SN Ramasamy","year":"2013","unstructured":"Ramasamy SN, Korb-Wells CS, Kannangara DR, Smith MW, Wang N, Roberts DM, et al. Allopurinol hypersensitivity: a systematic review of all published cases, 1950\u20132012. Drug Saf. 2013;36:953\u201380.","journal-title":"Drug Saf"},{"key":"174_CR11","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/jamainternmed.2015.3536","volume":"175","author":"CY Yang","year":"2015","unstructured":"Yang CY, Chen CH, Deng ST, Huang CS, Lin YJ, Chen YJ, et al. Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan. JAMA Intern Med. 2015;175:1550\u20137.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"174_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","volume":"71","author":"BY Thong","year":"2011","unstructured":"Thong BY, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011;71(5):684\u2013700. https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03774.x(review).","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"174_CR13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/ddg.12747","volume":"13","author":"M Paulmann","year":"2015","unstructured":"Paulmann M, Mockenhaupt M. Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy. J Dtsch Dermatol Ges. 2015;13(7):625\u201345. https:\/\/doi.org\/10.1111\/ddg.12747.","journal-title":"J Dtsch Dermatol Ges."},{"key":"174_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-214563","author":"B Solak","year":"2016","unstructured":"Solak B, Dikicier BS, Kara RO, Erdem T. DRESS syndrome potentially induced by allopurinol and triggered by influenza vaccine. BMJ Case Rep. 2016. https:\/\/doi.org\/10.1136\/bcr-2016-214563.","journal-title":"BMJ Case Rep."},{"key":"174_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","volume":"58","author":"S Halevy","year":"2008","unstructured":"Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, Naldi L, Dunant A, Viboud C, Roujeau JC, EuroSCAR Study Group. Allopurinol is the most common cause of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol. 2008;58:25\u201332.","journal-title":"J Am Acad Dermatol."},{"key":"174_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2165\/00128071-200001060-00003","volume":"1","author":"PO Fritsch","year":"2000","unstructured":"Fritsch PO, Sidoroff A. Drug-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis. Am J Clin Dermatol. 2000;1:349\u201360.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"174_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","volume":"81","author":"V Descamps","year":"2014","unstructured":"Descamps V, Ranger-Rogez S. DRESS syndrome. Jt Bone Spine. 2014;81(1):15\u201321. https:\/\/doi.org\/10.1016\/j.jbspin.2013.05.002.","journal-title":"Jt Bone Spine"},{"key":"174_CR18","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","volume":"124","author":"P Cacoub","year":"2011","unstructured":"Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, Roujeau JC. The DRESS syndrome: a literature review. Am J Med. 2011;124:588\u201397. https:\/\/doi.org\/10.1016\/j.amjmed.2011.01.017.","journal-title":"Am J Med"},{"key":"174_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-5-39","volume":"5","author":"T Harr","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome. Orphanet J Rare Dis. 2010;5:39. https:\/\/doi.org\/10.1186\/1750-1172-5-39.","journal-title":"Orphanet J Rare Dis."},{"issue":"6","key":"174_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40257-015-0158-0","volume":"16","author":"RP Dodiuk-Gad","year":"2015","unstructured":"Dodiuk-Gad RP, Chung WH, Valeyrie-Allanore L, Shear NH. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: an update. Am J Clin Dermatol. 2015;16(6):475\u201393.","journal-title":"Am J Clin Dermatol"},{"key":"174_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1586\/eci.11.66","volume":"7","author":"M Mockenhaupt","year":"2011","unstructured":"Mockenhaupt M. The current understanding of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011;7:803\u201313. https:\/\/doi.org\/10.1586\/eci.11.66(quiz 814-5).","journal-title":"Expert Rev Clin Immunol."},{"key":"174_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/09546630500375684","volume":"16","author":"VN Sehgal","year":"2005","unstructured":"Sehgal VN, Srivastava G. Toxic epidermal necrolysis (TEN) Lyell\u2019s syndrome. J Dermatolog Treat. 2005;16:278\u201386.","journal-title":"J Dermatolog Treat."},{"key":"174_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1540-9740.2005.03593.x","volume":"4","author":"A Baroni","year":"2005","unstructured":"Baroni A, Ruocco E. Lyell\u2019s syndrome. Skinmed. 2005;4:221\u20135.","journal-title":"Skinmed."},{"issue":"5","key":"174_CR24","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/jid.2012.510","volume":"133","author":"P Sekula","year":"2013","unstructured":"Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, Kardaun S, Sidoroff A, Liss Y, Schumacher M, Roujeau JC, RegiSCAR study group. Comprehensive survival analysis of a cohort of patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol. 2013;133(5):1197\u2013204.","journal-title":"J Invest Dermatol."},{"issue":"3","key":"174_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jaip.2017.01.025","volume":"5","author":"JG Peter","year":"2017","unstructured":"Peter JG, Lehloenya R, Dlamini S, et al. Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice. J Allergy Clin Immunol Pract. 2017;5(3):547\u201363. https:\/\/doi.org\/10.1016\/j.jaip.2017.01.025.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"8","key":"174_CR26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/ijd.12702","volume":"54","author":"J Lalosevic","year":"2015","unstructured":"Lalosevic J, Nikolic M, Gajic-Veljic M, Skiljevic D, Medenica L. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience. Int J Dermatol. 2015;54(8):978\u201384.","journal-title":"Int J Dermatol"},{"key":"174_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13601-017-0188-1","volume":"8","author":"B Sousa-Pinto","year":"2018","unstructured":"Sousa-Pinto B, Ara\u00fajo L, Freitas A, Correia O, Delgado L. Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis and erythema multiforme drug-related hospitalisations in a national administrative database. Clin Transl Allergy. 2018;8:2. https:\/\/doi.org\/10.1186\/s13601-017-0188-1.","journal-title":"Clin Transl Allergy"},{"issue":"11","key":"174_CR28","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2165\/00002018-200730110-00003","volume":"30","author":"L Valeyrie-Allanore","year":"2007","unstructured":"Valeyrie-Allanore L, Sassolas B, Roujeau JC. Drug-induced skin, nail and hair disorders. Drug Saf. 2007;30(11):1011\u201330 (Review. PubMed PMID: 17973540).","journal-title":"Drug Saf."},{"key":"174_CR29","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1517\/14740338.2015.1067301","volume":"14","author":"M Sessa","year":"2015","unstructured":"Sessa M, Rossi C, Mascolo A, Grassi E, Fiorentino S, Scavone C, Reginelli A, Rotondo A, Sportiello L. Suspected adverse reactions to contrast media in Campania Region (Italy): results from 14\u00a0years of post-marketing surveillance. Expert Opin Drug Saf. 2015;14:1341\u201351. https:\/\/doi.org\/10.1517\/14740338.2015.1067301.","journal-title":"Expert Opin Drug Saf."},{"key":"174_CR30","unstructured":"Guideline on good pharmacovigilance practices (GVP). Module VI. https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/guideline-good-pharmacovigilance-practices-gvp-module-vi-collection-management-submission-reports_en.pdf. Accessed 01 Aug 2019."},{"key":"174_CR31","unstructured":"ICH Topic E 2. A\u2014clinical safety data management: definitions and standards for expedited reporting. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-15.pdf. Accessed 01 Aug 2019."},{"key":"174_CR32","first-page":"S435","volume":"11","author":"AJ Luk","year":"2005","unstructured":"Luk AJ, Simkin PA. Epidemiology of hyperuricemia and gout. Am J Manag Care. 2005;11:S435\u201342 (quiz S465-8).","journal-title":"Am J Manag Care."},{"key":"174_CR33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jare.2017.04.006","volume":"8","author":"MEG Ramirez","year":"2017","unstructured":"Ramirez MEG, Bargman JM. Treatment of asymptomatic hyperuricemia in chronic kidney disease: a new target in an old enemy\u2014A review. J Adv Res. 2017;8:551\u20134. https:\/\/doi.org\/10.1016\/j.jare.2017.04.006.","journal-title":"J Adv Res."},{"key":"174_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fphar.2019.00011","volume":"10","author":"C Ferrajolo","year":"2019","unstructured":"Ferrajolo C, Sultana J, Ientile V, Scavone C, Scondotto G, Tari M, Trifir\u00f2 G, Rossi F, Capuano A. Gender differences in outpatient pediatric drug utilization: a cohort study from Southern Italy. Front Pharmacol. 2019;10:11. https:\/\/doi.org\/10.3389\/fphar.2019.00011.","journal-title":"Front Pharmacol."},{"key":"174_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/14740338.2016.1225720","volume":"15","author":"L Sportiello","year":"2016","unstructured":"Sportiello L, Rafaniello C, Sullo MG, Nica M, Scavone C, Bernardi FF, Colombo DM, Rossi F. No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region. Expert Opin Drug Saf. 2016;15:101\u20137.","journal-title":"Expert Opin Drug Saf."},{"key":"174_CR36","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3389\/fphar.2017.00607","volume":"8","author":"C Scavone","year":"2017","unstructured":"Scavone C, Sportiello L, Sullo MG, Ferrajolo C, Ruggiero R, Sessa M, Berrino PM, di Mauro G, Berrino L, Rossi F, Rafaniello C, Capuano A, BIO-Cam Group. Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study. Front Pharmacol. 2017;8:607. https:\/\/doi.org\/10.3389\/fphar.2017.00607.","journal-title":"Front Pharmacol."},{"key":"174_CR37","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3389\/fphar.2018.01003","volume":"9","author":"C Scavone","year":"2018","unstructured":"Scavone C, Rafaniello C, Brusco S, Bertini M, Menditto E, Orlando V, Trama U, Sportiello L, Rossi F, Capuano A. Did the new Italian law on mandatory vaccines affect adverse event following immunization\u2019s reporting? A Pharmacovigilance study in Southern Italy. Front Pharmacol. 2018;9:1003. https:\/\/doi.org\/10.3389\/fphar.2018.01003.","journal-title":"Front Pharmacol."},{"key":"174_CR38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2146\/ajhp080603","volume":"67","author":"KE Ward","year":"2010","unstructured":"Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: a review of the literature. Am J Health Syst Pharm. 2010;67:206\u201313. https:\/\/doi.org\/10.2146\/ajhp080603.","journal-title":"Am J Health Syst Pharm"},{"key":"174_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/jcpt.12754","volume":"44","author":"KD Nguyen","year":"2019","unstructured":"Nguyen KD, Tran TN, Nguyen MT, Nguyen HA, Nguyen HA Jr, Vu DH, Nguyen VD, Bagheri H. Drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: a subgroup approach to disproportionality analysis. J Clin Pharm Ther. 2019;44:69\u201377. https:\/\/doi.org\/10.1111\/jcpt.12754.","journal-title":"J Clin Pharm Ther"},{"issue":"14","key":"174_CR40","first-page":"2732","volume":"19","author":"L Ordo\u00f1ez","year":"2015","unstructured":"Ordo\u00f1ez L, Salgueiro E, Jimeno FJ, Manso G. Spontaneous reporting of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs. Eur Rev Med Pharmacol Sci. 2015;19(14):2732\u20137.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"174_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2019.08.004","author":"C Zhang","year":"2019","unstructured":"Zhang C, Van DN, Hieu C, Craig T. Drug-induced severe cutaneous adverse reactions: Determine the cause and prevention. Ann Allergy Asthma Immunol. 2019. https:\/\/doi.org\/10.1016\/j.anai.2019.08.004.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"174_CR42","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/bjd.14649","volume":"175","author":"MS Agier","year":"2016","unstructured":"Agier MS, Boivin N, Maruani A, Giraudeau B, Gouraud A, Haramburu F, Jean Pastor MJ, Machet L, Jonville-Bera AP. Risk assessment of drug-induced drug reaction with eosinophillia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database. Br J Dermatol. 2016;175(5):1067\u20139. https:\/\/doi.org\/10.1111\/bjd.14649.","journal-title":"Br J Dermatol"},{"issue":"5","key":"174_CR43","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/jcpt.12556","volume":"42","author":"H Taghvaye Masoumi","year":"2017","unstructured":"Taghvaye Masoumi H, Hadjibabaie M, Zarif-Yeganeh M, Arasteh O. Exacerbation of allopurinol-induced drug reaction with eosinophilia and systemic symptoms by teicoplanin: a case report. J Clin Pharm Ther. 2017;42(5):642\u20135. https:\/\/doi.org\/10.1111\/jcpt.12556.","journal-title":"J Clin Pharm Ther"},{"issue":"8","key":"174_CR44","doi-asserted-by":"publisher","first-page":"e1569","DOI":"10.7759\/cureus.1569","volume":"9","author":"H Waseem","year":"2017","unstructured":"Waseem H, Inayat F, Abduraimova M, Kamholz S. Allopurinol-induced drug reaction with eosinophilia and systemic symptoms syndrome: a cause of acalculous cholecystitis? Cureus. 2017;9(8):e1569. https:\/\/doi.org\/10.7759\/cureus.1569.","journal-title":"Cureus."},{"issue":"6","key":"174_CR45","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jaip.2016.07.005","volume":"4","author":"T Menter","year":"2016","unstructured":"Menter T, Tzankov A. Drug Reaction, Eosinophilia, and Systemic Symptoms (DRESS) syndrome associated with allopurinol leading to acute necrotizing eosinophilic myocarditis and death due to papillary muscle rupture. J Allergy Clin Immunol Pract. 2016;4(6):1262\u20134. https:\/\/doi.org\/10.1016\/j.jaip.2016.07.005.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"2","key":"174_CR46","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1016\/j.amjmed.2016.08.042","volume":"130","author":"YH Lien","year":"2017","unstructured":"Lien YH, Logan JL. Cross-reactions between allopurinol and febuxostat. Am J Med. 2017;130(2):e67\u20138. https:\/\/doi.org\/10.1016\/j.amjmed.2016.08.042.","journal-title":"Am J Med"},{"key":"174_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrrheum.2015.132","volume":"12","author":"LK Stamp","year":"2016","unstructured":"Stamp LK, Day RO, Yun J. Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Nat Rev Rheumatol. 2016;12:235\u201342.","journal-title":"Nat Rev Rheumatol"},{"key":"174_CR48","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/acr.21817","volume":"65","author":"SC Kim","year":"2013","unstructured":"Kim SC, Newcomb C, Margolis D, Roy J, Hennessy S. Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort study. Arthritis Care Res (Hoboken). 2013;65:578\u201384. https:\/\/doi.org\/10.1002\/acr.21817.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"174_CR49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3349\/ymj.2019.60.2.208","volume":"60","author":"MG Kang","year":"2019","unstructured":"Kang MG, Sohn KH, Kang DY, Park HK, Yang MS, Lee JY, Kang HR. Analysis of individual case safety reports of severe cutaneous adverse reactions in Korea. Yonsei Med J. 2019;60:208\u201315. https:\/\/doi.org\/10.3349\/ymj.2019.60.2.208.","journal-title":"Yonsei Med J"},{"key":"174_CR50","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.amjms.2018.11.018","volume":"357","author":"SS Gupta","year":"2019","unstructured":"Gupta SS, Sabharwal N, Patti R, Kupfer Y. Allopurinol-induced Stevens\u2013Johnson syndrome. Am J Med Sci. 2019;357:348\u201351. https:\/\/doi.org\/10.1016\/j.amjms.2018.11.018.","journal-title":"Am J Med Sci"},{"key":"174_CR51","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/pds.3937","volume":"25","author":"J Diphoorn","year":"2016","unstructured":"Diphoorn J, Cazzaniga S, Gamba C, Schroeder J, Citterio A, Rivolta AL, Vighi GD, Naldi L, REACT-Lombardia study group. Incidence, causative factors and mortality rates of Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry. Pharmacoepidemiol Drug Saf. 2016;25:196\u2013203. https:\/\/doi.org\/10.1002\/pds.3937.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"2","key":"174_CR52","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","volume":"7","author":"AR Wolfson","year":"2019","unstructured":"Wolfson AR, Zhou L, Li Y, Phadke NA, Chow OA, Blumenthal KG. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module. J Allergy Clin Immunol Pract. 2019;7(2):633\u201340. https:\/\/doi.org\/10.1016\/j.jaip.2018.08.013.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"4","key":"174_CR53","first-page":"399","volume":"96","author":"J Thammakumpee","year":"2013","unstructured":"Thammakumpee J, Yongsiri S. Characteristics of toxic epidermal necrolysis and Stevens\u2013Johnson syndrome: a 5-year retrospective study. J Med Assoc Thai. 2013;96(4):399\u2013406.","journal-title":"J Med Assoc Thai"},{"issue":"2","key":"174_CR54","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/bcp.13098","volume":"83","author":"P In\u00e1cio","year":"2017","unstructured":"In\u00e1cio P, Cavaco A, Airaksinen M. The value of patient reporting to the pharmacovigilance system: a systematic review. Br J Clin Pharmacol. 2017;83(2):227\u201346. https:\/\/doi.org\/10.1111\/bcp.13098.","journal-title":"Br J Clin Pharmacol"},{"key":"174_CR55","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00228-018-2569-3","volume":"75","author":"S Rodr\u00edguez-Mart\u00edn","year":"2019","unstructured":"Rodr\u00edguez-Mart\u00edn S, Mart\u00edn-Merino E, Lerma V, Rodr\u00edguez-Miguel A, Gonz\u00e1lez O, Gonz\u00e1lez-Herrada C, Ram\u00edrez E, Bell\u00f3n T, de Abajo FJ. Incidence of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study. Eur J Clin Pharmacol. 2019;75:237\u201346. https:\/\/doi.org\/10.1007\/s00228-018-2569-3.","journal-title":"Eur J Clin Pharmacol"},{"key":"174_CR56","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1523-1755.2004.00484.x","volume":"65","author":"A H\u00f8ieggen","year":"2004","unstructured":"H\u00f8ieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahl\u00f6f B, LIFE Study Group. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int. 2004;65:1041\u20139.","journal-title":"Kidney Int."},{"key":"174_CR57","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijcard.2017.11.083","volume":"252","author":"SG Wannamethee","year":"2018","unstructured":"Wannamethee SG, Papacosta O, Lennon L, Whincup PH. Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: the British Regional Heart Study. Int J Cardiol. 2018;252:187\u201392. https:\/\/doi.org\/10.1016\/j.ijcard.2017.11.083.","journal-title":"Int J Cardiol."},{"key":"174_CR58","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/rheumatology\/kew293","volume":"56","author":"C Ben Salem","year":"2017","unstructured":"Ben Salem C, Slim R, Fathallah N, Hmouda H. Drug-induced hyperuricaemia and gout. Rheumatology (Oxford). 2017;56:679\u201388. https:\/\/doi.org\/10.1093\/rheumatology\/kew293.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"174_CR59","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1468-3083.2011.04313.x","volume":"26","author":"L Atzori","year":"2012","unstructured":"Atzori L, Pinna AL, Mantovani L, Ferreli C, Pau M, Mulargia M, Aste N. Cutaneous adverse drug reactions to allopurinol: 10\u00a0year observational survey of the dermatology department\u2013Cagliari University (Italy). J Eur Acad Dermatol Venereol. 2012;26(11):1424\u201330. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04313.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"174_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15020310","author":"V P\u00e9rez-Jover","year":"2018","unstructured":"P\u00e9rez-Jover V, Mira JJ, Carratala-Munuera C, Gil-Guillen VF, Basora J, L\u00f3pez-Pineda A, Orozco-Beltr\u00e1n D. Inappropriate use of medication by elderly, polymedicated, or multipathological patients with chronic diseases. Int J Environ Res Public Health. 2018. https:\/\/doi.org\/10.3390\/ijerph15020310.","journal-title":"Int J Environ Res Public Health."},{"key":"174_CR61","doi-asserted-by":"publisher","first-page":"4320195","DOI":"10.1155\/2018\/4320195","volume":"2018","author":"SC Yang","year":"2018","unstructured":"Yang SC, Hu S, Zhang SZ, Huang JW, Zhang J, Ji C, Cheng B. The Epidemiology of Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis in China. J Immunol Res. 2018;2018:4320195. https:\/\/doi.org\/10.1155\/2018\/4320195.","journal-title":"J Immunol Res."},{"key":"174_CR62","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","volume":"22","author":"CC Chiou","year":"2008","unstructured":"Chiou CC, Yang LC, Hung SI, Chang YC, Kuo TT, Ho HC, Hu S, Hong HS, Chung WH. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol. 2008;22:1044\u20139. https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02585.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"174_CR63","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12016-017-8654-z","volume":"54","author":"M Lerch","year":"2018","unstructured":"Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54:147\u201376. https:\/\/doi.org\/10.1007\/s12016-017-8654-z.","journal-title":"Clin Rev Allergy Immunol"},{"key":"174_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/0378-6323.74964","volume":"77","author":"R Kumari","year":"2011","unstructured":"Kumari R, Timshina DK, Thappa DM. Drug hypersensitivity syndrome. Indian J Dermatol Venereol Leprol. 2011;77:7\u201315. https:\/\/doi.org\/10.4103\/0378-6323.74964.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"174_CR65","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/106002809302700317","volume":"27","author":"F Arellano","year":"1993","unstructured":"Arellano F, Sacrist\u00e1n JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother. 1993;27(3):337\u201343 (Review. PubMed PMID: 8453174).","journal-title":"Ann Pharmacother."},{"key":"174_CR66","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000069956","volume":"206","author":"S Tas","year":"2003","unstructured":"Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology. 2003;206:353\u20136.","journal-title":"Dermatology"},{"key":"174_CR67","first-page":"384","volume":"49","author":"HY Lee","year":"2008","unstructured":"Lee HY, Ariyasinghe JT, Thirumoorthy T. Allopurinol hypersensitivity syndrome: a preventable severe cutaneous adverse reaction? Singap Med J. 2008;49:384\u20137.","journal-title":"Singap Med J"},{"key":"174_CR68","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S1085-5629(96)80036-8","volume":"15","author":"M Mockenhaupt","year":"1996","unstructured":"Mockenhaupt M, Sch\u00f6pf E. Epidemiology of drug-induced severe skin reactions. Semin Cutan Med Surg. 1996;15:236\u201343.","journal-title":"Semin Cutan Med Surg"},{"key":"174_CR69","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/archderm.1991.01680050075007","volume":"127","author":"BL Strom","year":"1991","unstructured":"Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Shaw M, Tilson HH, Joseph M, Dai WS, Chen D, et al. A population-based study of Stevens\u2013Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol. 1991;127:831\u20138.","journal-title":"Arch Dermatol"},{"key":"174_CR70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","volume":"58","author":"J Schneck","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol. 2008;58:33\u201340.","journal-title":"J Am Acad Dermatol"},{"key":"174_CR71","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1590\/abd1806-4841.20176610","volume":"92","author":"LB Arantes","year":"2017","unstructured":"Arantes LB, Reis CS, Novaes AG, Carvalho MR, G\u00f6ttems LBD, Novaes MRCG. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals. An Bras Dermatol. 2017;92:661\u20137. https:\/\/doi.org\/10.1590\/abd1806-4841.20176610.","journal-title":"An Bras Dermatol"},{"key":"174_CR72","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/1078155214533368","volume":"21","author":"MJ Fallon","year":"2015","unstructured":"Fallon MJ, Heck JN. Fatal Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy. J Oncol Pharm Pract. 2015;21:388\u201392. https:\/\/doi.org\/10.1177\/1078155214533368.","journal-title":"J Oncol Pharm Pract"},{"key":"174_CR73","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(84)91807-5","volume":"1","author":"DJ Pennell","year":"1984","unstructured":"Pennell DJ, Nunan TO, O\u2019Doherty MJ, Croft DN. Fatal Stevens\u2013Johnson syndrome in a patient on captopril and allopurinol. Lancet. 1984;1:463.","journal-title":"Lancet"},{"key":"174_CR74","first-page":"196","volume":"44","author":"P Coutellier","year":"1989","unstructured":"Coutellier P. Delgrange B [Fatal toxic epidermolysis following administration of allopurinol]. Acta Clin Belg. 1989;44:196\u20138.","journal-title":"Acta Clin Belg"},{"key":"174_CR75","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/0019-5154.77557","volume":"56","author":"H Ranu","year":"2011","unstructured":"Ranu H, Jiang J, Ming PS. A case series of allopurinol-induced toxic epidermal necrolysis. Indian J Dermatol. 2011;56:74\u20136. https:\/\/doi.org\/10.4103\/0019-5154.77557.","journal-title":"Indian J Dermatol"},{"key":"174_CR76","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000102604","volume":"118","author":"B Fang","year":"2007","unstructured":"Fang B, Song Y, Ma J, Zhao RC. Severe epidermal necrolysis after Bortezomib treatment for multiple myeloma. Acta Haematol. 2007;118:65\u20137.","journal-title":"Acta Haematol"},{"key":"174_CR77","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2340\/00015555-1610","volume":"93","author":"Y Watanabe","year":"2013","unstructured":"Watanabe Y, Matsukura S, Isoda Y, Morita A, Aihara M, Kambara T. A case of toxic epidermal necrolysis induced by allopurinol with human herpesvirus-6 reactivation. Acta Derm Venereol. 2013;93:731\u20132. https:\/\/doi.org\/10.2340\/00015555-1610.","journal-title":"Acta Derm Venereol"},{"key":"174_CR78","doi-asserted-by":"publisher","first-page":"P91","DOI":"10.1186\/2045-7022-4-S3-P91","volume":"4","author":"MG Aversano","year":"2014","unstructured":"Aversano MG, Schroeder J, Citterio A, et al. Levofloxacin induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis overlap syndrome: case reports. Clin Transl Allergy. 2014;4:P91. https:\/\/doi.org\/10.1186\/2045-7022-4-S3-P91.","journal-title":"Clin Transl Allergy"},{"key":"174_CR79","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/jamainternmed.2014.1427","volume":"174","author":"C Carnovale","year":"2014","unstructured":"Carnovale C, Venegoni M, Clementi E. Allopurinol overuse in asymptomatic hyperuricemia: a teachable moment. JAMA Intern Med. 2014;174:1031\u20132. https:\/\/doi.org\/10.1001\/jamainternmed.2014.1427.","journal-title":"JAMA Intern Med"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-019-00174-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40801-019-00174-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-019-00174-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:52:00Z","timestamp":1608079920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40801-019-00174-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,17]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1007\/s40801-019-00174-7","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,17]]},"assertion":[{"value":"17 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was received for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"CS, CDM, RR, FFB, UT, MLA, CR and AC report no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}